{"id":"https://openalex.org/W4416635559","doi":"https://doi.org/10.1183/13993003.congress-2025.pa4722","title":"The lack of response to Omalizumab in patients with severe asthma is associated with IgE receptor mutations.","display_name":"The lack of response to Omalizumab in patients with severe asthma is associated with IgE receptor mutations.","publication_year":2025,"publication_date":"2025-09-27","ids":{"openalex":"https://openalex.org/W4416635559","doi":"https://doi.org/10.1183/13993003.congress-2025.pa4722"},"language":"en","primary_location":{"id":"doi:10.1183/13993003.congress-2025.pa4722","doi":"https://doi.org/10.1183/13993003.congress-2025.pa4722","is_oa":false,"landing_page_url":"https://doi.org/10.1183/13993003.congress-2025.pa4722","pdf_url":null,"source":{"id":"https://openalex.org/S4210207896","display_name":"European Respiratory Journal","issn_l":"0903-1936","issn":["0903-1936","1399-3003"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310317833","host_organization_name":"European Respiratory Society","host_organization_lineage":["https://openalex.org/P4310317833"],"host_organization_lineage_names":["European Respiratory Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Allergy and immunology","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5099015186","display_name":"Fatma Emre Turan Tasolar","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210128276","display_name":"Sa\u011fl\u0131k Bilimleri \u00dcniversitesi","ror":"https://ror.org/03k7bde87","country_code":"TR","type":"education","lineage":["https://openalex.org/I4210128276"]}],"countries":["TR"],"is_corresponding":false,"raw_author_name":"Fatma Emre Turan Tasolar","raw_affiliation_strings":["1Sa\u011fl\u0131k Bilimleri \u00dcniversitesi, \u0130stanbul, Turkey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Sa\u011fl\u0131k Bilimleri \u00dcniversitesi, \u0130stanbul, Turkey","institution_ids":["https://openalex.org/I4210128276"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013633834","display_name":"Ender Mehmet Co\u015fkunp\u0131nar","orcid":"https://orcid.org/0000-0002-1003-5544","observed_orcids":["https://orcid.org/0000-0002-1003-5544"]},"institutions":[{"id":"https://openalex.org/I4210128276","display_name":"Sa\u011fl\u0131k Bilimleri \u00dcniversitesi","ror":"https://ror.org/03k7bde87","country_code":"TR","type":"education","lineage":["https://openalex.org/I4210128276"]}],"countries":["TR"],"is_corresponding":false,"raw_author_name":"Ender Mehmet Co\u015fkunp\u0131nar","raw_affiliation_strings":["1Sa\u011fl\u0131k Bilimleri \u00dcniversitesi, \u0130stanbul, Turkey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Sa\u011fl\u0131k Bilimleri \u00dcniversitesi, \u0130stanbul, Turkey","institution_ids":["https://openalex.org/I4210128276"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5078175424","display_name":"Oktay Tasolar","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1303077703","display_name":"Ministry of Health","ror":"https://ror.org/00pkvys92","country_code":"TR","type":"government","lineage":["https://openalex.org/I1303077703"]}],"countries":["TR"],"is_corresponding":false,"raw_author_name":"Oktay Ta\u015folar","raw_affiliation_strings":["2Sa\u011fl\u0131k Bakanl\u0131\u011f\u0131, KOCAELI, Turkey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Sa\u011fl\u0131k Bakanl\u0131\u011f\u0131, KOCAELI, Turkey","institution_ids":["https://openalex.org/I1303077703"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"PA4722","last_page":"PA4722"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10051","display_name":"Asthma and respiratory diseases","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10051","display_name":"Asthma and respiratory diseases","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10877","display_name":"Allergic Rhinitis and Sensitization","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2723","display_name":"Immunology and Allergy"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11725","display_name":"Immunodeficiency and Autoimmune Disorders","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/omalizumab","display_name":"omalizumab","score":0.9559999704360962},{"id":"https://openalex.org/keywords/severe-asthma","display_name":"severe asthma","score":0.8920000195503235},{"id":"https://openalex.org/keywords/treatment-non-response","display_name":"treatment non-response","score":0.8330000042915344},{"id":"https://openalex.org/keywords/fcepsilonri","display_name":"Fc\u03b5RI","score":0.7089999914169312},{"id":"https://openalex.org/keywords/cd23","display_name":"CD23","score":0.7229999899864197},{"id":"https://openalex.org/keywords/genetic-polymorphism","display_name":"genetic polymorphism","score":0.5619999766349792},{"id":"https://openalex.org/keywords/biological-therapy","display_name":"biologic therapy","score":0.6980000138282776},{"id":"https://openalex.org/keywords/whole-exome-sequencing","display_name":"exome sequencing","score":0.828000009059906},{"id":"https://openalex.org/keywords/pharmacogenetics","display_name":"pharmacogenetics","score":0.3790000081062317}],"concepts":[{"id":"https://openalex.org/C2778564945","wikidata":"https://www.wikidata.org/wiki/Q415392","display_name":"Omalizumab","level":4,"score":0.9782000184059143},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.843999981880188},{"id":"https://openalex.org/C31467283","wikidata":"https://www.wikidata.org/wiki/Q912147","display_name":"Genotyping","level":4,"score":0.6743000149726868},{"id":"https://openalex.org/C141105273","wikidata":"https://www.wikidata.org/wiki/Q79455","display_name":"Immunoglobulin E","level":3,"score":0.5267000198364258},{"id":"https://openalex.org/C2776042228","wikidata":"https://www.wikidata.org/wiki/Q35869","display_name":"Asthma","level":2,"score":0.503000020980835},{"id":"https://openalex.org/C2777832160","wikidata":"https://www.wikidata.org/wiki/Q3306175","display_name":"Mepolizumab","level":4,"score":0.483599990606308},{"id":"https://openalex.org/C143660080","wikidata":"https://www.wikidata.org/wiki/Q7684883","display_name":"TaqMan","level":4,"score":0.4481000006198883},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4433000087738037},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.41850000619888306},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.39160001277923584},{"id":"https://openalex.org/C160798450","wikidata":"https://www.wikidata.org/wiki/Q4230870","display_name":"Concordance","level":2,"score":0.38850000500679016},{"id":"https://openalex.org/C16671776","wikidata":"https://www.wikidata.org/wiki/Q5420592","display_name":"Exome sequencing","level":4,"score":0.3824999928474426},{"id":"https://openalex.org/C163864487","wikidata":"https://www.wikidata.org/wiki/Q6901461","display_name":"Monoclonal","level":4,"score":0.3370000123977661},{"id":"https://openalex.org/C55775858","wikidata":"https://www.wikidata.org/wiki/Q1152227","display_name":"Pharmacogenetics","level":4,"score":0.33250001072883606},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.30559998750686646},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.30410000681877136},{"id":"https://openalex.org/C179786068","wikidata":"https://www.wikidata.org/wiki/Q16257937","display_name":"Molecular diagnostics","level":2,"score":0.3010999858379364},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.28119999170303345},{"id":"https://openalex.org/C135763542","wikidata":"https://www.wikidata.org/wiki/Q106016","display_name":"Genotype","level":3,"score":0.2671999931335449}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1183/13993003.congress-2025.pa4722","doi":"https://doi.org/10.1183/13993003.congress-2025.pa4722","is_oa":false,"landing_page_url":"https://doi.org/10.1183/13993003.congress-2025.pa4722","pdf_url":null,"source":{"id":"https://openalex.org/S4210207896","display_name":"European Respiratory Journal","issn_l":"0903-1936","issn":["0903-1936","1399-3003"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310317833","host_organization_name":"European Respiratory Society","host_organization_lineage":["https://openalex.org/P4310317833"],"host_organization_lineage_names":["European Respiratory Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Allergy and immunology","raw_type":"proceedings-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9907000064849854,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2983498257","https://openalex.org/W2779169641","https://openalex.org/W4224303436","https://openalex.org/W4210441622","https://openalex.org/W7169867606","https://openalex.org/W3112742104","https://openalex.org/W3017104430","https://openalex.org/W2750584686","https://openalex.org/W4394909238","https://openalex.org/W7100205854"],"abstract_inverted_index":{"According":[0],"to":[1,51,90,116,121,128,169,256],"the":[2,20,30,52,71,142,149,153,209,232,237,241],"GINA":[3,16],"2024":[4],"guidelines,":[5],"severe":[6,132],"asthma":[7],"is":[8,44,78,81,115,253],"defined":[9],"as":[10,95,97,165],"disease":[11],"requiring":[12],"treatment":[13,91,130],"based":[14],"on":[15],"levels":[17],"4-5":[18],"in":[19,75,131,141,212],"previous":[21,31],"year,":[22,32],"or":[23,33],"oral":[24],"corticosteroids":[25],"(OCS)":[26],"for":[27,58,156,203],"\u226550%":[28],"of":[29,70,84,112,214,240],"uncontrolled":[34],"despite":[35],"such":[36],"treatment.":[37,53,68,170],"For":[38],"patients":[39,85,98,104,150],"at":[40,157],"this":[41,113],"stage,":[42],"it":[43],"recommended":[45],"that":[46,148],"biological":[47],"molecules":[48,73],"are":[49,56,63],"added":[50],"Biological":[54],"therapies":[55],"promising":[57],"many":[59],"patients,":[60],"but":[61],"they":[62],"expensive":[64],"and":[65,103,126,167,199,227,236],"require":[66],"lifelong":[67],"One":[69],"first":[72],"used":[74,152],"biologic":[76],"therapy":[77],"omalizumab.":[79],"There":[80],"a":[82,88,107,118],"group":[83],"who":[86,99,105],"have":[87,106],"super-response":[89],"after":[92],"omalizumab":[93,129,154],"administration,":[94],"well":[96],"do":[100],"not":[101],"respond":[102],"partial":[108],"response.":[109],"The":[110,144,184],"aim":[111],"study":[114],"perform":[117],"molecular":[119,228],"assessment":[120],"make":[122],"decisions":[123],"about":[124],"response":[125,255],"non-response":[127],"asthma.":[133],"Fourty":[134],"volunteers":[135],"aged":[136],"18-65":[137],"years":[138],"were":[139,163,190,218,234],"included":[140],"study.":[143],"main":[145],"criterion":[146],"was":[147,175,195,243],"had":[151],"molecule":[155],"least":[158],"16":[159],"weeks.":[160],"Two":[161],"groups":[162,211],"formed":[164],"responders":[166],"non-responders":[168],"Whole":[171],"Exome":[172],"Sequencing":[173],"(WES)":[174],"performed":[176,196],"by":[177,187,192],"taking":[178],"peripheral":[179],"blood":[180],"samples":[181],"from":[182,231],"volunteers.":[183],"variants":[185],"obtained":[186,230],"WES":[188],"analysis":[189],"validated":[191],"PCR.":[193],"Genotyping":[194],"using":[197],"primers":[198],"Taqman":[200],"probes":[201],"specific":[202],"each":[204],"gene":[205],"region.":[206],"Differences":[207],"between":[208],"two":[210],"terms":[213],"IgEFc":[215],"receptor":[216],"polymorphism":[217],"evaluated.":[219],"Demographic":[220],"data,":[221,223],"clinical":[222],"routine":[224],"laboratory":[225],"tests":[226],"data":[229,242],"subjects":[233],"combined":[235],"statistical":[238],"significance":[239],"reported.":[244],"IgE":[245],"receptor-related":[246],"mutations":[247],"should":[248],"be":[249],"considered":[250],"when":[251],"there":[252],"no":[254],"Omalizumab.":[257]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2025-11-25T00:00:00"}